PELAIA, CORRADO
 Distribuzione geografica
Continente #
NA - Nord America 1.052
EU - Europa 659
AS - Asia 501
AF - Africa 11
SA - Sud America 8
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 2.239
Nazione #
US - Stati Uniti d'America 1.040
IT - Italia 428
SG - Singapore 398
DE - Germania 59
GB - Regno Unito 41
CN - Cina 39
SE - Svezia 34
HK - Hong Kong 22
FI - Finlandia 21
NL - Olanda 20
IN - India 14
CA - Canada 11
FR - Francia 11
EG - Egitto 8
CZ - Repubblica Ceca 7
AT - Austria 6
ES - Italia 6
AU - Australia 5
IE - Irlanda 5
MY - Malesia 5
RU - Federazione Russa 5
UA - Ucraina 5
EE - Estonia 4
PE - Perù 4
JP - Giappone 3
MA - Marocco 3
PT - Portogallo 3
TR - Turchia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
ID - Indonesia 2
IR - Iran 2
KR - Corea 2
PK - Pakistan 2
TH - Thailandia 2
BR - Brasile 1
CL - Cile 1
CY - Cipro 1
EU - Europa 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
MX - Messico 1
PH - Filippine 1
PL - Polonia 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 2.239
Città #
Singapore 179
Chandler 170
Santa Clara 159
Milan 68
Princeton 66
Lawrence 65
Catanzaro 42
Wilmington 41
London 36
Chicago 33
Ashburn 28
Boardman 28
Palermo 21
Hong Kong 20
Naples 18
San Nicola Manfredi 18
Rome 17
Des Moines 16
Helsinki 14
Bari 11
Munich 11
Redwood City 11
Troina 11
Florence 10
Norwalk 9
Galbiate 8
Ottawa 8
Redmond 8
Alessandria 7
Olomouc 7
Castrovillari 6
Seattle 6
Cosenza 5
Dublin 5
Hanover 5
Lamezia Terme 5
Padova 5
Amsterdam 4
Assago 4
Aversa 4
Beijing 4
Indore 4
Messina 4
Petaling Jaya 4
Providence 4
Rende 4
Sohag 4
Turku 4
West Jordan 4
Afragola 3
Brookline 3
Cerreto Guidi 3
Gravina in Puglia 3
Houston 3
Lima 3
Mascalucia 3
Pune 3
Taranto 3
Turin 3
Al Mansurah 2
Ankara 2
Ann Arbor 2
Bangkok 2
Bologna 2
Campbelltown 2
Council Bluffs 2
Fisciano 2
Foggia 2
Genoa 2
Girona 2
Guangzhou 2
Lisbon 2
Livorno 2
Lucca 2
Marseille 2
Mendicino 2
Mountain View 2
Nagold 2
Nuremberg 2
Paris 2
Phoenix 2
Putignano 2
Qalyubia 2
Reggio Emilia 2
Saracena 2
Saronno 2
Shanghai 2
Spadola 2
Taipei 2
Treviso 2
Verona 2
Vienna 2
Wuxi 2
Aiello Calabro 1
Amantea 1
Amasya 1
Anchorage 1
Ardabil 1
Atlanta 1
Augusta 1
Totale 1.330
Nome #
25-Hydroxy Vitamin D Detection Using Different Analytic Methods in Patients with Migraine 68
An Analytical Method for Assessing Optimal Storage Conditions of Gingival Crevicular Fluid and Disclosing a Peptide Biomarker Signature of Gingivitis by MALDI-TOF MS 57
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 50
Evaluation of a New Interface Combining High-Flow Nasal Cannula and CPAP 47
Benralizumab: From the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma 46
Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children 43
High-flow nasal cannula oxygen therapy for outpatients undergoing flexible bronchoscopy: a randomised controlled trial 43
MALDI MS-Based Investigations Targeting SARS-CoV-2 41
Hexagonal Mesoporous Silica as a Rapid, Efficient and Versatile Tool for MALDI-TOF MS Sample Preparation in Clinical Peptidomics Analysis: A Pilot Study. 40
Comparisons of two diaphragm ultrasound-teaching programs: a multicenter randomized controlled educational study. 37
Benralizumab in the treatment of severe asthma: design, development and potential place in therapy 36
Recognizing, quantifying and managing patient-ventilator asynchrony in invasive and noninvasive ventilation. 35
Rapid detection and identification of antimicrobial peptide fingerprints of nasal fluid by mesoporous silica particles and MALDI-TOF/TOF mass spectrometry: from the analytical approach to the diagnostic applicability in precision medicine 35
Uric acid and vascular damage in essential hypertension: Role of insulin resistance 34
Association Between Sleep Apnea and Valvular Heart Diseases 34
Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose 33
Clinical relevance of understanding mitogen-activated protein kinases involved in asthma 33
Effects of Sacubitril-Valsartan on Clinical, Echocardiographic, and Polygraphic Parameters in Patients Affected by Heart Failure With Reduced Ejection Fraction and Sleep Apnea 32
Fluid Challenge During Anesthesia: A Systematic Review and Meta-analysis. 32
Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma 32
Short term effect of sacubitril/valsartan on comprehensive geriatric assessment in chronic heart failure: a real life analysis 31
Biologics in severe asthma 31
Neuron-specific enolase serum levels in COVID-19 are related to the severity of lung injury 31
Nurse led protocols for control of glycaemia in critically ill patients: A systematic review 29
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 29
Gingival Crevicular Fluid Peptidome Profiling in Healthy and in Periodontal Diseases. 27
Nasal polyposis: Insights in epithelial-mesenchymal transition and differentiation of polyp mesenchymal stem cells 27
Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma 26
Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma 26
Assessment of cephalometric parameters and correlation with the severity of the obstructive sleep apnea syndrome 25
Device for Performing Spirometry in Total Laryngectomized Patients 25
Mapping the SARS-CoV-2–host protein–protein interactome by affinity purification mass spectrometry and proximity-dependent biotin labeling: A rational and straightforward route to discover host-directed anti-SARS-CoV-2 therapeutics 25
Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study 25
Patient-ventilator asynchrony in adult critically ill patients 25
New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant 24
Current Practice of High Flow through Nasal Cannula in Exacerbated COPD Patients 24
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness 23
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study 22
Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease 22
What is the Role of Sex-Related Differences in the Effectiveness and Safety of Biological Drugs used in Patients' Severe Asthma? 21
Asthma control during COVID-19 lockdown in patients with severe asthma under biological drug treatment 21
Predictors of renal function worsening in patients with chronic obstructive pulmonary disease (Copd): A multicenter observational study 21
Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis 20
Severe Eosinophilic Asthma: from the Pathogenic role of Interleukin-5 to the Therapeutic Action of Mepolizumab. 20
Electrical impedance tomography during spontaneous breathing trials and after extubation in critically ill patients at high risk for extubation failure: a multicenter observational study. 20
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 20
Intraoperative protective ventilation in patients undergoing major neurosurgical interventions: a randomized clinical trial 20
Short-term evaluation of dupilumab effects in patients with severe asthma and nasal polyposis 20
Real-life effects of benralizumab on allergic chronic rhinosinusitis and nasal polyposis associated with severe asthma 19
Tezepelumab: A potential new biological therapy for severe refractory asthma 19
Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid-19 pandemic 18
Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study 18
Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13 18
Effects of continuous positive airway pressure on comprehensive geriatric assessment and cognitive function in elderly patients with obstructive sleep apnea syndrome 18
Effect of Statins on Lung Cancer Molecular Pathways: A Possible Therapeutic Role 18
Real-Life Effects of Omalizumab on Chronic Rhinosinusitis with Nasal Polyposis 18
Primary mucosal melanoma presenting with a unilateral nasal obstruction of the left inferior turbinate 18
Real-life effectiveness of mepolizumab on forced expiratory flow between 25% and 75% of forced vital capacity in patients with severe eosinophilic asthma 18
Association between right ventricular dysfunction and adverse cardiac events in mild COPD patients 17
Role of p38-mitogen-activated protein kinase in COPD: pathobiological implications and therapeutic perspectives 17
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study 16
Benefits of secretion clearance with high frequency percussive ventilation in tracheostomized critically ill patients: a pilot study 16
Intrinsic laryngeal lipoma treated with transoral Co2 laser microsurgery: An unusual case report 16
MALDI MS-Based Investigations for SARS-CoV-2 Detection 16
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study 15
Switch from omalizumab to benralizumab in allergic patients with severe eosinophilic asthma: A real-life experience from Southern Italy 15
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets 14
Dupilumab for the treatment of asthma 14
Pharmacotherapeutic strategies for critical asthma syndrome: a look at the state of the art 14
Monoclonal antibodies targeting alarmins: A new perspective for biological therapies of severe asthma 14
Do Comorbidities Influence the Response to Biologics in Severe Asthma? 13
Mechanical ventilation in brain injured patients: seeing the forest for the trees 13
Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: results of a single-centre observational study 13
Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real life 13
Switching from omalizumab to mepolizumab: real-life experience from Southern Italy 13
Indacaterol/glycopyrronium/mometasone fixed dose combination for uncontrolled asthma 13
Complications during Veno-Venous Extracorporeal Membrane Oxygenation in COVID-19 and Non-COVID-19 Patients with Acute Respiratory Distress Syndrome 12
Phenotyping severe asthma: a rationale for biologic therapy 12
Cost-Sensitive Models to Predict Risk of Cardiovascular Events in Patients with Chronic Heart Failure 11
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience 11
Real-life Mepolizumab effectiveness in severe eosinophilic asthmatics with nasal polyposis 11
Interleukin-5 in the Pathophysiology of Severe Asthma 11
Molecular Targets for Biological Therapies of Severe Asthma 11
Role of p38 mitogen-activated protein kinase in asthma and COPD: Pathogenic aspects and potential targeted therapies 11
Oxygenation strategies during flexible bronchoscopy: a review of the literature 11
Therapeutic effects of benralizumab assessed in patients with severe eosinophilic asthma: Real-life evaluation correlated with allergic and non-allergic phenotype expression 11
Mepolizumab Effectiveness and Allergic Status in Real Life 11
Real-World Evaluation of Dupilumab in the Long-Term Management of Eosinophilic Chronic Rhinosinusitis with Nasal Polyps: A Focus on IL-4 and IL-13 Receptor Blockade 10
Difficult-To-Treat and Severe Asthma: Can Real-World Studies On Effectiveness of Biological Treatments Change the Lives of Patients? 10
An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPD 10
Clinical remission in severe asthma: lights and shadows on an ambitious goal 10
New potential biomarkers for early chronic kidney disease diagnosis in patients with different glucose tolerance status 10
Real-life evaluation of mepolizumab efficacy in patients with severe eosinophilic asthma, according to atopic trait and allergic phenotype 10
Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications 10
Novel Biological Therapies for Severe Asthma Endotypes 9
Effects of High-Flow Nasal Cannula on Right Heart Dysfunction in Patients with Acute-on-Chronic Respiratory Failure and Pulmonary Hypertension 9
Novel Biological Therapies for Severe Asthma Endotypes 9
TSLP and HMGB1: Inflammatory Targets and Potential Biomarkers for Precision Medicine in Asthma and COPD 9
Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence. 9
Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: Results of a single-centre observational study 9
Totale 2.179
Categoria #
all - tutte 35.418
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.418


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202036 0 0 0 0 0 0 0 0 0 0 6 30
2020/2021141 3 0 5 10 22 13 3 9 57 10 5 4
2021/2022233 5 5 29 31 7 8 22 40 29 22 34 1
2022/2023600 137 32 40 23 60 52 26 51 80 27 52 20
2023/2024380 67 45 32 27 12 75 6 17 6 25 24 44
2024/20251.040 166 18 26 32 191 215 109 49 165 53 16 0
Totale 2.454